P物质通过改变胆管细胞和肝星状细胞衰老差异增加肝纤维化
研究探讨P物质(SP)及其NK-1受体(NK-1R)在胆汁淤积性肝损伤中对肝纤维化的调控作用。在胆管结扎(BDL)小鼠、Mdr2-/-小鼠及体外细胞实验中,SP/NK-1R轴通过增强肝星状细胞衰老、减少胆管细胞衰老而促进肝纤维化,NK-1R拮抗剂L-733,060可减轻Mdr2-/-小鼠肝纤维化。
要点
- BDL和Mdr2-/-小鼠中速激肽前体1(编码SP)和NK-1R表达较野生型增加。
- NK-1R敲除减轻BDL诱导的肝纤维化,L-733,060减轻Mdr2-/-小鼠肝纤维化。
- SP/NK-1R轴经改变肝星状细胞与胆管细胞衰老差异调控肝纤维化。
核心结论
- 结果证明SP/NK-1R轴在胆汁淤积性肝损伤中通过改变细胞衰老调控肝纤维化。
研究设计与样本
- 采用BDL或假手术的野生型与NK-1R敲除(NK-1R-/-)小鼠,以及给予NK-1R拮抗剂L-733,060或生理盐水的Mdr2-/-小鼠。
- 野生型小鼠接受腹腔注射SP或生理盐水,并纳入体外培养的肝星状细胞和胆管细胞实验。
- 比较BDL和Mdr2-/-小鼠与野生型小鼠的速激肽前体1和NK-1R表达,并比较原发性硬化性胆管炎患者肝样本与健康对照的表达。
主要发现
- BDL和Mdr2-/-小鼠中速激肽前体1(编码SP)和NK-1R表达较野生型小鼠增加。
- 原发性硬化性胆管炎患者肝样本中速激肽前体1和NK-1R表达显著高于健康对照。
- NK-1R敲除减轻BDL诱导的肝纤维化,L-733,060减轻Mdr2-/-小鼠肝纤维化,表现为天狼星红染色、纤维化基因和蛋白表达减少及血清和胆管细胞上清中转化生长因子-β1水平降低。
- NK-1R-/-小鼠(BDL手术)或L-733,060治疗的Mdr2-/-小鼠肝纤维化减轻与肝星状细胞衰老增强、胆管细胞衰老减少相关。
- 体外L-733,060抑制SP诱导的肝星状细胞和胆管细胞纤维化基因表达,部分逆转SP诱导的肝星状细胞衰老基因表达降低及胆管细胞衰老相关基因表达增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Substance P (SP) is involved in the proliferation of cholangiocytes in bile duct-ligated (BDL) mice and human cholangiocarcinoma growth by interacting with the neurokinin-1 receptor (NK-1R). To identify whether SP regulates liver fibrosis during cholestasis, wild-type or NK-1R knockout (NK-1R-/- ) mice that received BDL or sham surgery and multidrug resistance protein 2 knockout (Mdr2-/- ) mice treated with either an NK-1R antagonist (L-733,060) or saline were used. Additionally, wild-type mice were treated with SP or saline intraperitoneally. In vivo, there was increased expression of tachykinin precursor 1 (coding SP) and NK-1R in both BDL and Mdr2-/- mice compared to wild-type mice. Expression of tachykinin precursor 1 and NK-1R was significantly higher in liver samples from primary sclerosing cholangitis patients compared to healthy controls. Knockout of NK-1R decreased BDL-induced liver fibrosis, and treatment with L-733,060 resulted in decreased liver fibrosis in Mdr2-/- mice, which was shown by decreased sirius red staining, fibrosis gene and protein expression, and reduced transforming growth factor-β1 levels in serum and cholangiocyte supernatants. Furthermore, we observed that reduced liver fibrosis in NK-1R-/- mice with BDL surgery or Mdr2-/- mice treated with L-733,060 was associated with enhanced cellular senescence of hepatic stellate cells and decreased senescence of cholangiocytes. In vitro, L-733,060 inhibited SP-induced expression of fibrotic genes in hepatic stellate cells and cholangiocytes; treatment with L-733,060 partially reversed the SP-induced decrease of senescence gene expression in cultured hepatic stellate cells and the SP-induced increase of senescence-related gene expression in cultured cholangiocytes. CONCLUSION: Collectively, our results demonstrate the regulatory effects of the SP/NK-1R axis on liver fibrosis through changes in cellular senescence during cholestatic liver injury. (Hepatology 2017;66:528-541).
引用
- Wan Y, Meng F, Wu N, et al. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells. Hepatology. 2017. PMID: 28256736. doi:10.1002/hep.29138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。